The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Open accessAbstract
BACKGROUND: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). OBJECTIVES: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. METHODS: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I² statistic, and conducted meta-analyses. RESULTS: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9% (95% CI: 8.76%-35.0%), while it was 14.8% for alcohol abuse, 5.83% for bipolar disorder, 23.7% (95% CI: 17.4%-30.0%) for depression, 2.5% for substance abuse, and 4.3% (95% CI: 0%-10.3%) for psychosis. CONCLUSION: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A comprehensive systematic review of 118 studies on psychiatric comorbidities in MS found that psychiatric comorbidities were common; in particular, the prevalence of diagnosed anxiety and depression were estimated at 21.9 and 23.7%, respectively [53].”
From Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap (2022) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“MS patients show increased levels of anxiety and depression compared to healthy participants, and these conditions affect more than 20% of patients [8,21,22,23].”
From Biopsychosocial Correlates of Quality of Life in Multiple Sclerosis Patients (2022) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Marrie, R., Cohen, J., Stüve, O., Trojano, M., Sørensen, P., Reingold, S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis · doi:10.1177/1352458514564491 · Cited by 762
Self-citationNeyeloff, J. L., Fuchs, S. C. P. C., & Moreira, L. B. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-52 · Cited by 731
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Depression and multiple sclerosis
Sadovnick, A. D., Remick, R. A., Allen, J. B., Swartz, E. S., Yee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, J. P., Kastrukoff, L. F., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.628 · Cited by 536
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700511 · Cited by 506
Quality of life in patients with multiple sclerosis
Janardhan, V., & Bakshi, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00312-x · Cited by 489
Lobentanz, I. S., Asenbaum, S., Vass, K., Sauter, C., Klosch, G., Kollegger, H., Kristoferitsch, W., & Zeitlhofer, J. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00257.x · Cited by 439
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424
Cited by
Sorted by citations
Items 201–300 of 519
Challenges in Diagnosis and Therapeutic Strategies in Late-Onset Multiple Sclerosis
Nociti, V., Romozzi, M., & Massimiliano Mirabella, A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14040400 · Cited by 17
Uccelli, M. M., Traversa, S., & Ponzio, M. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.07.039 · Cited by 15
Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis
Bargiela, D., Bianchi, M. T., Westover, M. B., Chibnik, L. B., Healy, B. C., Jager, P. L. D., & Xia, Z. (2017) · Neurology · doi:10.1212/wnl.0000000000003612 · Cited by 15
Factors associated with perceived need for mental health care in multiple sclerosis
Orr, J., Bernstein, C. N., Graff, L. A., Patten, S. B., Bolton, J. M., Sareen, J., Marriott, J. J., Fisk, J. D., & Marrie, R. A. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.043 · Cited by 15
Self-citationParks, N. E., Andreou, P., Marrie, R. A., Fisk, J. D., Bhan, V., & Kirkland, S. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103249 · Cited by 16
Self-citationSabé, M., & Sentissi, O. (2021) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2021.1973506 · Cited by 16
Potentially modifiable associates of anxiety in people with multiple sclerosis: a systematic review
Fahy, A., & Maguire, R. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2021.2022776 · Cited by 15
The Neuropsychiatric Approach to the Assessment of Patients in Neurology
Trapp, N. T., Martyna, M. R., Siddiqi, S., & Bajestan, S. N. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1745741 · Cited by 15
Association between limbic system lesions and anxiety in persons with multiple sclerosis.
Hillyer, A., Sharma, M., Kuurstra, A., Rosehart, H., Menon, R., & Morrow, S. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105021 · Cited by 12
Migraine and functional neurological disorder (FND)—a review of comorbidity and potential overlap
Stone, J., Coebergh, J. A., Khoja, L., Butler, M., Nicholson, T. R., & Dodick, D. W. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf288 · Cited by 15
Incident depression in patients diagnosed with multiple sclerosis: a multi‐database study
Persson, R., Lee, S., Yood, M. U., Wagner, M. R., Minton, N., Niemcryk, S. J., Lindholm, A., Evans, A. M., & Jick, S. S. (2020) · European Journal of Neurology · doi:10.1111/ene.14314 · Cited by 14
Lipid profile: causal relationship on cognitive performance in multiple sclerosis?
Hernández-Ledesma, A. L., Rodríguez-Méndez, A. J., Gallardo-Vidal, L. S., García-Gasca, T., Alatorre-Cruz, J. M., García‐Solís, P., López, J. V. R., & Solís‐S, J. C. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-06011-3 · Cited by 15
Bahmani, D. S., & Motl, R. W. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102878 · Cited by 17
Zarghami, A., Hussain, M. A., Campbell, J. A., Ezegbe, C., van der Mei, I. A. F., Taylor, B. V., & Claflin, S. B. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103562 · Cited by 15
Liu, F., Alfarhan, M., Baker, L., Shenoy, N., Liao, Y., Henry-Ojo, H. O., Somanath, P. R., & Narayanan, S. P. (2022) · Cells · doi:10.3390/cells11244100 · Cited by 14
Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies.
Moghadasi, A., Pourmand, S., Sharifian, M., Minagar, A., & Sahraian, M. (2016) · Neurologic clinics · doi:10.1016/j.ncl.2015.08.002 · Cited by 13
Finlayson, M. L., Akbar, N., Turpin, K. V. L., & Smyth, P. S. (2019) · BMC Neurology · doi:10.1186/s12883-019-1367-6 · Cited by 14
Gedik, Z. (2020) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.14744/dajpns.2019.00061 · Cited by 14
The impact of social media use on depression in multiple sclerosis patients
Farpour, H. R., Hoveidaei, A. H., Habibi, L., Moosavi, M., & Farpour, S. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01407-1 · Cited by 14
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Trials · doi:10.1186/s13063-021-05726-3 · Cited by 13
Smyth, P. S., Watson, K. E., Hamarneh, Y. N. A., & Tsuyuki, R. T. (2022) · BMC Neurology · doi:10.1186/s12883-022-02809-9 · Cited by 13
Shafiee, A., Soltani, H., Athar, M. M. T., Jafarabady, K., & Mardi, P. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104922 · Cited by 13
Kremer, I., Jongen, P. J., Evers, S., Hoogervorst, E. L. J., Verhagen, W. I. M., & Hiligsmann, M. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01479-w · Cited by 13
van der Linden, M. L., van Schie, P. E. M., Hjalmarsson, E., Andreopoulou, G., Verheul, M. H. G., & von Walden, F. (2022) · Journal of Rehabilitation Medicine · doi:10.2340/jrm.v53.1393 · Cited by 13
Sabidó, M., & Munschauer, R. (2017) · BMC Neurology · doi:10.1186/s12883-017-0831-4 · Cited by 13
Anxiety in Argentinian patients with multiple sclerosis: Prevalence and associated factors
Chertcoff, A. S., Curbelo, M. C., Bauer, J. J., Ferrandina, F., Martinez, A., Steinberg, J. D., & Carrá, A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102042 · Cited by 13
Comorbid disease burden among MS patients 1968–2012: A Swedish register–based cohort study
Smith, K. A., Burkill, S. M., Hiyoshi, A., Olsson, T. P., Bahmanyar, S., Wormser, D., Geissbühler, Y., Moore, A., Kharat, V., & Montgomery, S. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520910497 · Cited by 13
Weld-Blundell, I., Grech, L., Borland, R., White, S. L., das Nair, R., & Marck, C. H. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059637 · Cited by 15
Gateway reflex: neural activation-mediated immune cell gateways in the central nervous system
Kamimura, D., Ohki, T., Arima, Y., & Murakami, M. (2018) · International Immunology · doi:10.1093/intimm/dxy034 · Cited by 12
Pauli, F. D., Zinganell, A., Böttcher, B., Walde, J. F., Auer, M., Barket, R., Berek, K., Egger, A., Griesmacher, A., Sukalo, N., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15696 · Cited by 13
Sesel, A.-L., Sharpe, L., Beadnall, H. N., Barnett, M. H., Szabó, M., & Naismith, S. L. (2020) · Journal of Medical Internet Research · doi:10.2196/19309 · Cited by 12
Huang, Y.-C., Chien, W., Chung, C., Chang, H., Kao, Y., Wan, F.-J., Huang, S.-H., Chung, R., Wang, R. S., Wang, B., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s268360 · Cited by 13
Kever, A., & Leavitt, V. M. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211037581 · Cited by 12
Piliavska, K., Dantlgraber, M., Dettmers, C., Jöbges, M., Liepert, J., & Schmidt, R. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1077838 · Cited by 12
Montanari, E., Rottoli, M., Maimone, D., Confalonieri, P. A., Plewnia, K., Frigo, M., Francia, A., Pala, A., Losignore, N. A., Ragonese, P., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.02.047 · Cited by 11
Lazo-Gómez, R., Velázquez, G. D. L. L. G., Mireles-Jacobo, D., & Sotomayor-Sobrino, M. A. (2019) · Clinical Neurophysiology Practice · doi:10.1016/j.cnp.2019.01.004 · Cited by 11
Marck, C. H., Hunter, A., Butler, E. G., Allan, M., Edward, K., Giles, A., Kulkarni, J., Rajendran, D., Shaw, S., & Grech, L. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103362 · Cited by 11
Feasibility trial of a telehealth support group intervention to reduce anxiety in multiple sclerosis
Kever, A., Aguerre, I. M., Vargas, W. S., Farber, R. S., Levine, L., Riley, C., Vasquez, M., & Leavitt, V. M. (2022) · Clinical Rehabilitation · doi:10.1177/02692155221107077 · Cited by 11
Do Hungarian multiple sclerosis care units fulfil international criteria?
Kokas, Z., Sandi, D., Fricska‐Nagy, Z., Füvesi, J., Biernacki, T., Köves, Á., Fazekas, F., Birkás, A. J., Katona, G., Kovács, K., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264328 · Cited by 13
Bipolar spectrum disorders in neurologic disorders
Digiovanni, A., Ajdinaj, P., Russo, M., Sensi, S. L., ONOFRJ, M. C., & Thomas, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1046471 · Cited by 10
Sleep Disorders and Fatigue among Patients with MS: The Role of Depression, Stress, and Anxiety
Mohammadi, N. Z., Kianimoghadam, A. S., Mikaeili, N., Asgharian, S. S., Jafari, M., & Masjedi‐Arani, A. (2024) · Neurology Research International · doi:10.1155/2024/6776758 · Cited by 11
Monaghan, P. G., VanNostrand, M., Takla, T. N., & Fritz, N. E. (2025) · Sensors · doi:10.3390/s25061780 · Cited by 10
Murley, C., Tinghög, P., Karampampa, K., Hillert, J. A., Alexanderson, K. A. E., & Friberg, E. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039228 · Cited by 10
Busch, A.-K., & Fringer, A. (2022) · Journal of Primary Care & Community Health · doi:10.1177/21501319221119142 · Cited by 10
Nociti, V., & Romozzi, M. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111524 · Cited by 10
Oh, J., Gagné-Brosseau, M.-S., Guenette, M. D., Larochelle, C., Lemieux, F., Menon, S., Morrow, S. A., Poliquin‐Lasnier, L., Roy-Hewitson, C., Rush, C., et al. (2018) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2018.7 · Cited by 10
Blaney, C., Sommer, J. L., El-Gabalawy, R. M., Bernstein, C. N., Walld, R., Hitchon, C. A., Bolton, J. M., Sareen, J., Patten, S. B., Singer, A. G., et al. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000854 · Cited by 11
Self-citationMaltby, V. E., Lea, R. A., Ribbons, K., Lea, M. G., Schofield, P. W., & Lechner‐Scott, J. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102037 · Cited by 10
Reliability and validity of the multiple sclerosis resiliency scale (MSRS)
Hughes, A. J., Patel, K. K., Fitzgerald, K. C., Brown, A. J., Gromisch, E. S., & Mowry, E. M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116983 · Cited by 10
Radulović, L., Eraković, J., & Roganović, M. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102380 · Cited by 10
Leekoff, M. L., Culpepper, W. J., Jin, S., Lee‐Wilk, T., & Wallin, M. T. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211058361 · Cited by 9
Migraine in multiple sclerosis patients: potential links and treatment approach
Gklinos, P., & Mitsikostas, D. D. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2262384 · Cited by 9
Bove, R. M., Applebee, A., Bawden, K., Fine, C., Shah, A. A., Avila, R. L., Belviso, N., Branco, F., Fong, K., Lewin, J. B., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105738 · Cited by 10
Aparicio-Castro, E., Candeliere-Merlicco, A., Santa, C. M., & Villaverde, R. (2024) · Neurology Perspectives · doi:10.1016/j.neurop.2024.100181 · Cited by 10
Marrie, R. A., Bolton, J. M., Ling, Y. (., Bernstein, C. N., Krysko, K. M., Li, P., McKay, K. A., Pequeno, P., Razaz, N., Rotstein, D., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000210170 · Cited by 9
Self-citationGoischke, H.-K. (2019) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s204555 · Cited by 9
Psychosocial difficulties of individuals with multiple sclerosis: the PARADISE-24 questionnaire
Giovannetti, A. M., Schiavolin, S., Raggi, A., Quintas, R. M. M., Černiauskaitė, M., Confalonieri, P. A., Mantegazza, R., Clerici, V. T., Antozzi, C. G., Brenna, G., et al. (2016) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0000000000000194 · Cited by 9
Predictors of hospitalization in a Canadian MS population: A matched cohort study
Al‐Sakran, L., Marrie, R. A., Blackburn, D. F., Knox, K. B., & Evans, C. D. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102028 · Cited by 9
Self-citationAn At-home Positive Psychology Intervention for Individuals with Multiple Sclerosis
Freedman, M. E., Healy, B. C., Huffman, J. C., Chitnis, T., Weiner, H. L., & Glanz, B. I. (2020) · International Journal of MS Care · doi:10.7224/1537-2073.2020-020 · Cited by 9
Lozano-Soto, E., Cruz-Gómez, Á. J., Gutiérrez, R., González, M., Sanmartino, F., Rashid-López, R., Espinosa‐Rosso, R., Forero, L., & González-Rosa, J. J. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa088 · Cited by 9
Psychotherapie in der neurologischen Rehabilitation
Schmidt, R., Piliavska, K., Maier-Ring, D., van Husen, D. K., & Dettmers, C. (2017) · Aktuelle Neurologie · doi:10.1055/s-0043-104525 · Cited by 9
Dubrall, D., Pflock, R., Kosinska, J., Schmid, M. C., Bleich, M., Himmerkus, N., Offermanns, S., Schwaninger, M., & Sachs, B. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14787 · Cited by 8
Psychopharmacology of multiple sclerosis
Patten, S. B. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00018-6 · Cited by 8
Ouallet, J., Radat, F., Créange, A., Abdellaoui, M., Heinzlef, O., Giannesini, C., Hautecœur, P., Lamargue-Hamel, D., Deloire, M., Brochet, B., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116739 · Cited by 8
Lower Urinary Tract Symptoms and Depression in Patients with Multiple Sclerosis.
Tudor, K. I., Pašić, M. B., Škegro, S. N., Bakula, M., Nemir, J., Mustač, F., Vidrih, B., Pašić, H., Vujević, L., Rajič, F., et al. (2020) · PubMed · Cited by 8
Prevalence of comorbidities in multiple sclerosis patients with neurogenic bladder
Declemy, A., Haddad, R., Chesnel, C., Charlanes, A., Breton, F. L., Ismaël, S. S., & Amarenco, G. (2021) · The French Journal of Urology · doi:10.1016/j.purol.2020.10.011 · Cited by 8
Maggio, M. G., Stagnitti, M. C., Calatozzo, P., Formica, S., Latella, D., Manuli, A., Avena, G., Oddo, V., & Calabrò, R. S. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103533 · Cited by 8
Neurobehavioral burden of multiple sclerosis with nanotheranostics
Sriramoju, B., Kanwar, R., & Kanwar, J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s82768 · Cited by 7
Neural stimulations regulate the infiltration of immune cells into the CNS
Kamimura, D., & Murakami, M. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12912 · Cited by 9
Mental health and frailty in people with multiple sclerosis: unraveling a complex relationship
Worikat, N. A., Zanotto, A., Sosnoff, J. J., & Zanotto, T. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1387618 · Cited by 7
Stein, C., O’Keeffe, F. M., McManus, C., Tubridy, N. J., Gaughan, M., McGuigan, C., & Bramham, J. (2023) · Journal of Neuropsychology · doi:10.1111/jnp.12327 · Cited by 8
Almweisheer, S., Bernstein, C. N., Graff, L. A., Patten, S. B., Bolton, J. M., Fisk, J. D., Hitchon, C. A., Marriott, J. J., & Marrie, R. A. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073782 · Cited by 8
Self-citationHassan, S. S., Darwish, E. S., Ahmed, G. K., Azmy, S. R., & Haridy, N. A. (2023) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-023-00702-x · Cited by 7
Maier, H. B., Stadler, J., Deest‐Gaubatz, S., Borlak, F., Türker, S. N., Konen, F. F., Seifert, J., Kesen, C., Frieling, H., Bleich, S., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115725 · Cited by 8
Maggio, M. G., Benenati, A., Impellizzeri, F., Rizzo, A., Barbera, M., Cannavò, A., Gregoli, V., Morone, G., Chirico, F., Quartarone, A., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14121227 · Cited by 7
Bisson, E. J., Fakolade, A. O., Pétrin, J., Lamarre, J., & Finlayson, M. L. (2017) · Clinical Rehabilitation · doi:10.1177/0269215517698734 · Cited by 7
Mohammadyfar, M. A., Azizpour, M., Najafi, M., & Nooripour, R. (2017) · Nordic Psychology · doi:10.1080/19012276.2017.1362989 · Cited by 7
Narita, Z. C., Satake, N., Sato, W., & Takano, H. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12014 · Cited by 7
Mahdi, O., Baharuldin, M. T. H., Nor, N. H. M., Chiroma, S. M., Jagadeesan, S., & Moklas, M. A. M. (2021) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524921666210127110028 · Cited by 6
Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes
Diržiuvienė, B., & Mickevičienė, D. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103558 · Cited by 7
Gromisch, E. S., Neto, L. O., Sloan, J., Tyry, T. M., & Foley, F. W. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103079 · Cited by 7
Behavioral disorders in multiple sclerosis: a comprehensive review
Jellinger, K. A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02816-9 · Cited by 6
Jorge, A., André, A. L., Rocha, A. L., Figueiredo, C., Santos, M. L. P. D. L., Freitas, E., Sousa, L., Shamasna, M., Salgado, V., de Sá, J., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103154 · Cited by 6
Capacity limitations in neurology patients, with and without comorbid mental disorders
Neue, D. C., Linden, M., & Muschalla, B. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.110928 · Cited by 6
Tyszka, E. E., Bozinov, N., & Briggs, F. B. S. (2022) · International Journal of MS Care · doi:10.7224/1537-2073.2021-108 · Cited by 6
Motor and Non-Motor Factors of Concern About Falling and Fear of Falling in Multiple Sclerosis
Takla, T. N., Matsuda, P. N., Herring, T. E., Daugherty, A. M., & Fritz, N. E. (2024) · Neurology Report · doi:10.1097/npt.0000000000000490 · Cited by 6
Dysfonction sexuelle féminine et sclérose en plaques : étude cas-témoins
Masmoudi, R., Aissi, M., Halouani, N., Fathallah, S., Louribi, I., Aloulou, J., Amami, O., & Frih, M. (2018) · The French Journal of Urology · doi:10.1016/j.purol.2018.07.001 · Cited by 6
Valet, M., Stoquart, G. G., de Broglie, C., Francaux, M., & Lejeune, T. M. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13756 · Cited by 6
Lee, B., Reyes, A., Rumrill, S. P., & Bishop, M. L. (2022) · Rehabilitation Counseling Bulletin · doi:10.1177/00343552221080434 · Cited by 6
Bhattacharjee, S., Yegezu, Z., Kollecas, K., Duhrkopf, K., Hashemi, L., & Greene, N. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s305154 · Cited by 8
Silveira, S. L., Cederberg, K. L. J., Jeng, B., Sikes, E. M., Sandroff, B. M., Jones, C. D., & Motl, R. W. (2021) · Disability and health journal · doi:10.1016/j.dhjo.2021.101163 · Cited by 6
Subgroup Analysis of Individuals with Multiple Sclerosis Showing Cognitive Resilience
Randolph, J. J., Randolph, J. S., & Wishart, H. A. (2021) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acab067 · Cited by 6
Depression readmission risk is elevated in multiple sclerosis compared to other chronic illnesses
Schorr, E. M., Kurz, D., Rossi, K. C., Zhang, M., Yeshokumar, A. K., Jetté, N., & Dhamoon, M. S. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211051316 · Cited by 6
Furber, K. L., Agten, M. V., Evans, C. D., Haddadi, A., Doucette, J. R., & Nazarali, A. J. (2017) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s71986 · Cited by 6
Soltani, E., Izadi, S., Sharifi, P., & Poursadeghfard, M. (2022) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.113524 · Cited by 5
Marrie, R. A., Lix, L. M., Bolton, J. M., Fisk, J. D., Fitzgerald, K. C., Graff, L. A., Hitchon, C. A., Kowalec, K., Marriott, J. J., Patten, S. B., et al. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111415 · Cited by 5
Self-citationSchenk, A., Popa, C. O., Cojocaru, C. M., Marian, Ș., Maier, S., & Bălașa, R. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21101264 · Cited by 5
Scandiffio, J., Langer, L. K., Senthilnathan, V., Feng, G., Sureshkumar, A., Bromberg, M., Babineau, J., Donkers, S. J., Knox, K. B., Bruno, T. R., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13315-6 · Cited by 8
Ghafoor, D. D., Ahmad, D. O., Najmuldeen, H. H. R., Mohammed, S. J., Jalal, P. J., Mustafa, F. S., Alghofaili, F., Zangana, B. A., & Al-Bajalan, S. J. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02012-5 · Cited by 5
Comorbidity and modifiable risk factors in multiple sclerosis
Zhang, Y., Ruth, D., & Giovannoni, G. (2026) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251404455 · Cited by 5
Metadata
- Authors
- Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N.
- Affiliations
- University of Manitoba (CA)
- Scientific and Clinical Review Associates, LLC, USA
- Cleveland Clinic (US)
- Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA
- Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy
- Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark
- University of Alabama at Birmingham (US)
- Corresponding author
- Marrie, Ruth Ann
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2015-01-12
- Volume
- 21
- Issue
- 3
- Pages
- 305-317
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- PMC
- PMC4429164
- OpenAlex
- W2105913548
- Cited by
- 519
- References
- 136
- Citations by year
- 2026: 42 · 2025: 31 · 2024: 45 · 2023: 46 · 2022: 52 · 2021: 68 · 2020: 48 · 2019: 38 · 2018: 43 · 2017: 47 · 2016: 43 · 2015: 16
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Multiple Sclerosis Journal (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- mediaTUM (Technical University of Munich) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- U.S. Department of Defense
- National Multiple Sclerosis Society
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- Cleveland Clinic
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- MedDay Pharmaceuticals
- National Institutes of Health
- Genentech
- EMD Serono
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, psychiatric comorbidity, depression, anxiety, alcohol abuse, bipolar disorder, substance abuse, psychosis, incidence, prevalence, quality of life, fatigue
- MeSH terms
- Mental Disorders, Humans, Multiple Sclerosis, Comorbidity, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
